Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Estonia Pharmaceuticals and Healthcare Report Q' returned 25 results - Page 1 of 2  FEATURED RESULTS Maven Semantic Healthcare Database (SME Package) The Top 100 European Manufacturers Of Finished Pharmaceuticals The Top 60 European Manufacturers Of Generic Pharmaceuticals OTC Pharmaceuticals in Europe Canada Pharmaceuticals & Healthcare Report Q1 2008   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Estonia Pharmaceuticals and Healthcare Report Q2 2011   Business Monitor International, Feb 2011, Pages: 79 . To facilitate currency conversions, unless otherwise stated, all figures in Estonia’s Q211 Pharmaceuticals & Healthcare Report have now been converted into euros. Some historic figures are shown in the Estonian Estonia Pharmaceuticals and Healthcare Report Q4 2010   Business Monitor International, Aug 2010, Pages: 73 Business Monitor International's Estonia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government Estonia Pharmaceuticals and Healthcare Report Q1 2011   Business Monitor International, Nov 2010, Pages: 73 ) - Pfizer - Novartis - Sanofi-Aventis - Merck & Co - Grindeks (includes Tallinn Pharmaceutical Plant) Estonia Pharmaceuticals and Healthcare Report Q1 2011 Estonia Pharmaceuticals and Healthcare Report Q1 2012   Business Monitor International, Nov 2011, Pages: 79 - GlaxoSmithKline (GSK) - Pfizer - Novartis - Sanofi-Aventis - Merck & Co - Grindeks (incorporating Tallinn Pharmaceutical Plant) Estonia Pharmaceuticals and Healthcare Report Q1 2012 Estonia Pharmaceuticals and Healthcare Report Q2 2010   Business Monitor International, Feb 2010, Pages: 71 - Ratings Overview - Table: Pharmaceutical Business Environment Indicators - Weighting - Table: Weighting Of Components - Sources - Forecast Tables Estonia Pharmaceuticals and Healthcare Report Q2 2010 Estonia Pharmaceuticals and Healthcare Report Q1 2010   Business Monitor International, Nov 2009, Pages: 89 - Forecast Tables - GlaxoSmithKline - Pfizer - Novartis - Sanofi-Aventis - Merck & Co - Grindeks (includes Tallinn Pharmaceutical Plant) Estonia Pharmaceuticals and Healthcare Report Q1 2010 Estonia Pharmaceuticals & Healthcare Report Q1 2008   Business Monitor International, Feb 2008, Pages: 57 The Estonia Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Estonias pharmaceuticals and healthcare industry. The Estonian pharmaceutical Czech Republic Pharmaceuticals and Healthcare Report Q4 2010   Business Monitor International, Oct 2010, Pages: 84 score – behind only Slovenia and Estonia – are weighted and combined to deliver the Czech Republic’s top position in the Pharmaceuticals & Healthcare Business Environment Ratings for Q410 Latvia Pharmaceuticals and Healthcare Report Q2 2010   Business Monitor International, Feb 2010, Pages: 64 - Weighting - Table: Weighting Of Components - Sources - Forecast Tables - Pfizer - GlaxoSmithKline - Sanofi-Aventis - Novartis - Merck & Co Latvia Pharmaceuticals and Healthcare Report Q2 2010 Latvia Pharmaceuticals and Healthcare Report Q3 2011   Business Monitor International, May 2011, Pages: 88 SmithKline - Sanofi-Aventis - Novartis - Merck & Co, Latvia Pharmaceuticals and Healthcare Report Q3 2011 Lithuania Pharmaceuticals and Healthcare Report Q1 2010   Business Monitor International, Jan 2010, Pages: 70 Pharmaceuticals and Healthcare Report Q1 2010 Greece Pharmaceuticals and Healthcare Report Q3 2007   Business Monitor International, Oct 2007, Pages: 62 The Greece Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Greeces pharmaceuticals and healthcare industry. The Greek pharmaceutical Latvia Pharmaceuticals and Healthcare Report Q2 2008   Business Monitor International, April 2008, Pages: 54 The Latvia Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Latvias pharmaceuticals and healthcare industry. Latvia is the second-largest Turkey Pharmaceuticals & Healthcare Report Q1 2009   Business Monitor International, Jan 2009, Pages: 86 BMI's Turkey Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Turkey's pharmaceuticals and healthcare industry. Turkey represents one of the most Czech Republic Pharmaceuticals and Healthcare Report Q4 2009   Business Monitor International, Oct 2009, Pages: 79 Zeneca - Bristol-Myers Squibb - Sanofi-Aventis - Walmark - Zentiva (incorporating Sicomed) Czech Republic Pharmaceuticals and Healthcare Report Q4 2009 Lithuania Pharmaceuticals and Healthcare Report Q1 2009   Business Monitor International, Feb 2009, Pages: 67 - Merck & Co - Sanofi-Aventis - Valentis - Sanitas - Sicor Biotech Lithuania Pharmaceuticals and Healthcare Report Q1 2009 Lithuania Pharmaceuticals and Healthcare Report Q3 2008   Business Monitor International, Aug 2008, Pages: 60 Of Components 59 Sources 59 - GlaxoSmithKline - Pfizer - Novartis - Merck & Co - Sanofi-Aventis - Valentis - Sanitas - Sicor Biotech Lithuania Pharmaceuticals and Healthcare Report Q3 2008 Lithuania Pharmaceuticals and Healthcare Report Q4 2008   Business Monitor International, Oct 2008, Pages: 65 - Novartis - Merck & Co - Sanofi-Aventis - Valentis - Sanitas - Sicor Biotech Lithuania Pharmaceuticals and Healthcare Report Q4 2008 Czech Republic Pharmaceuticals and Healthcare Report Q3 2007   Business Monitor International, Aug 2007, Pages: 59 in the Czech Republic is in a state of flux as detailed in the Q307 Czech Republic Pharmaceuticals & Healthcare Report. Proposed reforms to the system include the introduction of flat charges for prescriptions, as well Antivirals - Global Strategic Business Report   Global Industry Analysts, Inc., Oct 2006, Pages: 699 Valeant Pharmaceuticals to Develop Viramidine(R) II-68 Biota Discovers a New Group of Antiviral Drugs against RSV II-68 Serum Launches Q-Vac, a Combination Vaccine II-68 Chongqing Jiachen to Produce Results:  First -   Prev -   1 -   2 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network